Omega Therapeutics Crecimiento futuro
Future controles de criterios 0/6
Información clave
7.8%
Tasa de crecimiento de los beneficios
17.8%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Biotechs | 24.5% |
Tasa de crecimiento de los ingresos | 60.1% |
Rentabilidad financiera futura | n/a |
Cobertura de analistas | Good |
Última actualización | 18 Jun 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Omega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy'
Mar 31Is Omega Therapeutics (NASDAQ:OMGA) Weighed On By Its Debt Load?
Feb 28Omega Therapeutics: The Next Weight Loss Drug Runner
Jan 16Omega Therapeutics: Starting 2024 With A Bang
Jan 10Omega Therapeutics GAAP EPS of -$0.54 in-line, revenue of $0.48M beats by $0.43M
Aug 04Omega Therapeutics gets FDA nod to start liver cancer trial of lead drug OTX-2002
Jul 14Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 27 | -121 | -97 | -63 | 4 |
12/31/2025 | 2 | -93 | -83 | -70 | 8 |
12/31/2024 | 5 | -79 | -92 | -56 | 7 |
3/31/2024 | 5 | -92 | -79 | -75 | N/A |
12/31/2023 | 3 | -97 | -94 | -92 | N/A |
9/30/2023 | 3 | -108 | -101 | -99 | N/A |
6/30/2023 | 3 | -112 | -102 | -100 | N/A |
3/31/2023 | 2 | -108 | -105 | -103 | N/A |
12/31/2022 | 2 | -103 | -100 | -99 | N/A |
9/30/2022 | 1 | -93 | -92 | -90 | N/A |
6/30/2022 | 1 | -85 | -83 | -82 | N/A |
3/31/2022 | 0 | -75 | -72 | -70 | N/A |
12/31/2021 | 0 | -68 | -59 | -58 | N/A |
9/30/2021 | N/A | -57 | -52 | -50 | N/A |
6/30/2021 | N/A | -47 | -43 | -40 | N/A |
3/31/2021 | N/A | -38 | -33 | -31 | N/A |
12/31/2020 | N/A | -29 | -28 | -26 | N/A |